---

Consultant Paediatric and Perinatal Pathologist, and Clinical Lead for Paediatric Histopathology at Royal Manchester Children's Hospital, Manchester Foundation Trust, UK

Missing from the diagnostic toolbox? The comprehensive integration of multi-omics data can significantly enhance the diagnostic capabilities of pathologists, particularly in the field of pediatric and perinatal pathology. This approach provides a more detailed and holistic understanding of diseases, leading to improved diagnostic accuracy.

By analyzing the complete DNA sequence, pathologists can identify genetic mutations, copy number variations, and other genomic alterations associated with congenital disorders, developmental anomalies, and rare pediatric diseases. Examining RNA expression profiles helps in understanding the gene expression changes in diseased versus healthy tissues. This can be particularly useful in identifying conditions that might not have clear genetic mutations but show altered gene expression patterns. Studying the protein profiles of tissues can provide insights into the functional consequences of genetic and transcriptomic changes, revealing altered pathways and mechanisms at the protein level. Finally, analysis of metabolites offers a snapshot of the metabolic state of cells and tissues, which can be altered in various diseases, including metabolic disorders common in neonates and infants.

Multi-omics data enables the identification of specific molecular signatures of diseases, facilitating the development of personalized treatment plans tailored to each patient’s genetic and molecular profile. This approach is particularly crucial for rare and complex pediatric conditions where standard treatments may be ineffective. Integrating multi-omics data can help identify biomarkers that predict disease progression and treatment response, aiding in the development of more effective and personalized management strategies.

By integrating genomics, transcriptomics, proteomics, and metabolomics data, pathologists can obtain a comprehensive understanding of the underlying mechanisms of pediatric and perinatal diseases. This holistic approach can reveal novel disease pathways and potential therapeutic targets. 

Multi-omics integration enables the identification of new disease subtypes based on molecular characteristics, rather than solely relying on clinical presentation. This can refine disease classification and enhance diagnostic accuracy. Multi-omics approaches also contribute to the identification of novel biomarkers for early detection, prognosis, and monitoring of treatment response, providing pathologists with additional tools for precise disease classification.

In addition, multi-omics data can identify novel targets for drug development, potentially resulting in innovative treatments for pediatric and perinatal diseases. Multi-omics research promotes collaboration among pathologists, geneticists, bioinformaticians, and other specialists, leading to a more interdisciplinary approach to disease diagnosis and treatment.

By integrating multi-omics data into their diagnostic toolkit, pediatric and perinatal pathologists can enhance diagnostic accuracy, facilitate personalized medicine, gain deeper insights into disease mechanisms, and optimize patient care.

Controversial opinion? AI and machine learning will significantly reduce the need for human pathologists in routine diagnostics. The worry amongst pathologists is that AI and machine learning advancements will eventually lead to a dramatic reduction in the number of human pathologists required for routine diagnostic tasks, potentially rendering many aspects of traditional pathology obsolete. There are arguments both in favor and against this viewpoint. 

AI algorithms, particularly deep learning models, have demonstrated capabilities in image analysis that rival or even surpass human pathologists in terms of speed and accuracy for certain tasks, such as identifying cancerous cells or grading tumors. Unlike human pathologists, AI systems can continuously learn and improve as they are exposed to more data. This continuous improvement could lead to increasingly precise diagnostic capabilities. AI can perform routine diagnostic tasks at a fraction of the cost of human labor. This cost efficiency is particularly attractive to healthcare systems facing budgetary constraints. AI systems can process vast amounts of data quickly, making them highly scalable solutions for pathology labs facing high volumes of cases. Unlike human pathologists, AI systems are not subject to fatigue, bias, or variability in performance, which can lead to more consistent and objective diagnoses. AI can help standardize diagnostic criteria and reduce inter-observer variability, leading to more uniform diagnostic outcomes.

Nevertheless, numerous diagnostic decisions necessitate a profound comprehension of the clinical context, patient history, and subtle histopathological characteristics that AI may not fully apprehend. Human expertise is paramount in diagnosing rare and complex cases where patterns may not be well-represented in training datasets. Establishing accountability for diagnostic errors made by AI systems presents substantial ethical and legal challenges. Patients and clinicians may be hesitant to place complete trust in AI. Pathologists play a pivotal role in conveying diagnoses and discussing treatment options with patients and their families, necessitating empathy and human interaction. Effective collaboration with other medical professionals often relies on nuanced human communication that AI cannot replicate. AI systems demand high-quality, meticulously annotated training data. 

Inconsistent data quality and the absence of standardized datasets can impede AI effectiveness. Integrating AI into current pathology workflows and healthcare systems poses practical challenges, encompassing costs, and training requirements.

While AI and machine learning hold great promise for transforming pathology, the notion that they will drastically reduce the need for human pathologists remains controversial. The future of pathology is likely to involve a hybrid approach, where AI augments human expertise rather than replaces it. However, the potential for AI to reshape the field in ways that could diminish the traditional role of pathologists cannot be entirely dismissed. This opinion sparks important discussions about the ethical, practical, and professional implications of AI in medicine.

Attracting talent… Attracting highly skilled scientists to the field of pediatric and perinatal pathology necessitates addressing several crucial factors that influence career decisions. To achieve this, some of the following strategies could be considered:

• Introduce medical students and trainees to pediatric and perinatal pathology through rotations, lectures, projects, and workshops. Emphasize the unique and impactful nature of the work by sharing compelling stories and case studies that illustrate the vital role of pediatric and perinatal pathologists in diagnosing and managing rare and complex conditions. 
• Where dedicated training programmes do not exist, develop, and promote fellowship programs that provide in-depth training in pediatric and perinatal pathology, offering hands-on experience with diverse cases. 
• Establish mentorship programs that connect trainees with experienced pathologists who can provide guidance, support, and career advice. 
• Offer flexible work schedules, part-time positions, and opportunities for remote work to enhance work-life balance. 
• Create a supportive and collaborative work environment that fosters professional growth and job satisfaction. 
• Clearly outline the various career pathways within pediatric and perinatal pathology, including opportunities in clinical practice, research, academia, and industry. 
• Promote opportunities for professional development, including continuing education, leadership roles, and participation in professional organizations. 
• Increase funding for research in pediatric and perinatal pathology to support innovative projects and attract researchers interested in making significant contributions to the field.

By implementing these strategies, we can attract more talented medics to this critical field and ensure the continued advancement of pediatric and perinatal pathology.